BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15967785)

  • 1. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.
    Lang GA; Illarionov PA; Glatman-Freedman A; Besra GS; Lang ML
    Int Immunol; 2005 Jul; 17(7):899-908. PubMed ID: 15967785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
    Lang GA; Maltsev SD; Besra GS; Lang ML
    Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
    Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
    J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
    Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
    J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells.
    van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS
    Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
    J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
    Lang GA; Exley MA; Lang ML
    Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
    Cheng L; Ueno A; Cho S; Im JS; Golby S; Hou S; Porcelli SA; Yang Y
    J Immunol; 2007 Mar; 178(5):2755-62. PubMed ID: 17312118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules.
    Chen X; Wang X; Keaton JM; Reddington F; Illarionov PA; Besra GS; Gumperz JE
    J Immunol; 2007 May; 178(10):6181-90. PubMed ID: 17475845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.
    Dougan SK; Salas A; Rava P; Agyemang A; Kaser A; Morrison J; Khurana A; Kronenberg M; Johnson C; Exley M; Hussain MM; Blumberg RS
    J Exp Med; 2005 Aug; 202(4):529-39. PubMed ID: 16087713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
    Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
    J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolipid antigen processing for presentation by CD1d molecules.
    Prigozy TI; Naidenko O; Qasba P; Elewaut D; Brossay L; Khurana A; Natori T; Koezuka Y; Kulkarni A; Kronenberg M
    Science; 2001 Jan; 291(5504):664-7. PubMed ID: 11158680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.
    Chen Q; Ross AC
    Exp Biol Med (Maywood); 2007 Apr; 232(4):488-94. PubMed ID: 17392484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
    Singh AK; Wilson MT; Hong S; Olivares-Villagómez D; Du C; Stanic AK; Joyce S; Sriram S; Koezuka Y; Van Kaer L
    J Exp Med; 2001 Dec; 194(12):1801-11. PubMed ID: 11748281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells.
    Elewaut D; Lawton AP; Nagarajan NA; Maverakis E; Khurana A; Honing S; Benedict CA; Sercarz E; Bakke O; Kronenberg M; Prigozy TI
    J Exp Med; 2003 Oct; 198(8):1133-46. PubMed ID: 14557411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.